Can a new nerve block beat standard pain relief for shoulder surgery?

NCT ID NCT03691922

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether a newer nerve block, called the Erector Spinae Plane (ESP) block, provides better pain relief after arthroscopic shoulder surgery than the standard periarticular infiltration (PAI) of local anesthetic. Half of the participants will receive the ESP block before surgery, while the other half will get the standard infiltration. The study measures pain scores and opioid use in the recovery room and for the first 24 hours after surgery, aiming to find a technique that reduces pain with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Erector Spinae Plane (ESP) block with bupivacaine and epinephrine, compared to periarticular infiltration (PAI) with the same anesthetic
What this could lead to
If the ESP block works better, it could offer a safer, more effective way to manage pain after shoulder surgery, reducing opioid use and side effects.
What could go wrong
This is a small, early-stage trial, and the ESP block may not prove superior to the standard approach. There are also risks like nerve block complications or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHROSCOPIC SHOULDER SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, L8N 4A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.